Prognostic implications of Fas-ligand expression in nasopharyngeal carcinoma

研究成果: Article同行評審

15 引文 斯高帕斯(Scopus)

摘要

Background. In nasopharyngeal carcinoma (NPC), Fas-ligand (Fas-L)-mediated apoptosis might contribute to the immune privilege of tumors. In some cancers, dysregulation of Fas-L protein in tumors might lead to disease progression. The purpose of this study was to evaluate the correlations between Fas-L expression and the clinical outcomes in patients with NPC. Methods. We recruited 78 patients with primary NPC, classified clinical stages according to the 1997 American Joint Committee on Cancer staging system, and assessed Fas-L with immunohistochemical methods. Results. Forty-one (53%) of 78 patients were Fas-L-positive. The prevalence was 0%, 57%, 58%, and 82% from stages I to IV, respectively (p < .001). Fas-L expression was associated with the N classification (p = .05) but not the T classification. Patients with positive Fas-L expression had a lower rate of disease-free survival and overall survival (p = .01 for all log-rank tests). Conclusion. Patients with NPC with Fas-L-positive tumors had higher clinical stages and lymph node metastasis at diagnosis and poorer disease-free survival and overall survival; therefore, Fas-L expression may be a potential biomarker of prognosis.

原文English
頁(從 - 到)977-983
頁數7
期刊Head and Neck
26
發行號11
DOIs
出版狀態Published - 2004 十一月 1

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

指紋 深入研究「Prognostic implications of Fas-ligand expression in nasopharyngeal carcinoma」主題。共同形成了獨特的指紋。

引用此